`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`v.
`MERCK SHARP & DOHME CORP.
`Patent Owner.
`U.S. Patent No. 7,326,708 to Cypes et al.
`Issue Date: February 5, 2008
`Title: Phosphoric Acid Salt of a Dipeptidyl Peptidase-IV Inhibitor
`Inter Partes Review No.: IPR2020-00040
`
`PETITIONER’S UPDATED POWER OF ATTORNEY
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`US_145835261v1_391026-00257
`
`
`
`PETITIONER’S POWER OF ATTORNEY
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc.,
`
`having a principal place of business at 781 Chestnut Ridge Road, Morgantown,
`
`WV, 26505, hereby appoints the following practitioners as its attorneys to transact
`
`all business in the United States Patent & Trademark Office Association with any
`
`inter partes review of U.S. Patent No 7,326,708:
`
`Lead Counsel
`Jitendra Malik, Ph.D.
`Reg. No. 55,823
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite
`2900
`Charlotte, NC 28202-4213
`jitty.malik@katten.com
`
`Back-up Counsel
`Alissa M. Pacchioli
`Reg. No. 74,252
`alissa.pacchioli@katten.com
`
`Christopher W. West, Ph.D.
`Reg. No. 74,724
`christopher.west@katten.com
`
`Heike S. Radeke, Ph.D.
`Reg. No. 75,394
`Heike.Radeke@katten.com
`
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`
`Lance Soderstrom
`Reg. No. 65,405
`lance.soderstrom@katten.com
`Katten Muchin Rosenman LLP
`575 Madison Avenue
`New York, NY 10022-2585
`
`and all practitioners associated with Customer Number 27160.
`
`US_145835261v1_391026-00257
`
`
`
`I have the authority to execute this document on behalf of Mylan
`Pharmaceuticals Inc.
`
`fl
`Items qmzuw; .
`
`TLOMAS D. Samkxh§
`Ase- 00
`
`Date: Octeber———%6-}9',
`
`US~145835261v1_391026-00257
`
`g + ( L Lu Z. G
`e f
`I
`
`
`
`CERTIFICATION OF SERVICE ON PATENT OWNER
`
`Pursuant to 37 C.F.R. §§ 42.6(e), 42.8(b)(4), and 42.105, the undersigned
`
`certifies that on September 17, 2020, a complete copy of the Petitioner’s Updated
`
`Power of Attorney, was served via email to Patent Owner’s counsel at:
`
`sfisher@wc.com
`
`jberniker@wc.com
`
`smahaffy@wc.com
`
`asheh@wc.com
`
`bgenderson@wc.com
`
`ebaumgarten@wc.com
`
`azolan@wc.com
`
`kzullow@goodwinprocter.com
`
`sfischer@goodwinprocter.com
`
`jwong@winston.com
`
`ZCohen@winston.com
`
`CKlein@winston.com
`
`Cfundakowski@winston.com
`
`rfaegenburg@lernerdavid.com
`
`tvanbuskirk@lernerdavid.com
`
`mteschner@lernerdavid.com
`
`ERapalino@goodwinlaw.com
`
`
`
`Dated: September 17, 2020
`
`Respectfully submitted,
`
`Katten Muchin Rosenman LLP
`
`/Jitendra Malik /
`Jitendra Malik (Reg. No. 55,823)
`
`for Petitioner Mylan
`Lead Counsel
`Pharmaceuticals, Inc.
`
`